Heart rate as an independent predictor of long term mortality of acute heart failure patients in sinus rhythm according to their ejection fraction: data from the AHEAD registry.


Journal

European journal of internal medicine
ISSN: 1879-0828
Titre abrégé: Eur J Intern Med
Pays: Netherlands
ID NLM: 9003220

Informations de publication

Date de publication:
08 2020
Historique:
received: 19 10 2019
revised: 15 02 2020
accepted: 06 04 2020
pubmed: 22 4 2020
medline: 16 2 2021
entrez: 22 4 2020
Statut: ppublish

Résumé

Heart rate (HR) at admission in patients with acute heart failure (AHF) has been shown to be an important risk marker of in-hospital mortality. However, its relation with mid and long-term prognosis as well as the impact of Ejection Fraction (EF) is unknown. Our objective was to study the relationship between long-term survival and HR at admission depending on EF in a cohort of patients hospitalized for AHF. We analyzed the data of 2335 patients in sinus rhythm hospitalized for AHF from AHEAD registry. Patients with cardiogenic shock and AHF from surgical or non-cardiac etiology were excluded. Survival rates at 6 and 12 months were 84.8% and 78% respectively. Increased age, decreased diastolic BP, lack of PCI during hospitalization, increased creatinine level and increased HR (with different cut-offs according to EF categories) were found as predictors whatever the EF at 6 and 12 months. Optimal prognostic cut-offs of heart rate were identified for Heart Failure with reduced EF at 100 bpm, for Heart Failure with mid-range EF at 90 bpm and for Heart Failure with preserved EF at 80 bpm for both 6 and 12 months. Our study suggests that HR at admission appears to be an independent prognostic parameter in AHF patients in sinus rhythm irrespective of EF and can be used to classify patients according to the severity of the disease.

Sections du résumé

BACKGROUND
Heart rate (HR) at admission in patients with acute heart failure (AHF) has been shown to be an important risk marker of in-hospital mortality. However, its relation with mid and long-term prognosis as well as the impact of Ejection Fraction (EF) is unknown. Our objective was to study the relationship between long-term survival and HR at admission depending on EF in a cohort of patients hospitalized for AHF.
METHODS
We analyzed the data of 2335 patients in sinus rhythm hospitalized for AHF from AHEAD registry. Patients with cardiogenic shock and AHF from surgical or non-cardiac etiology were excluded.
RESULTS
Survival rates at 6 and 12 months were 84.8% and 78% respectively. Increased age, decreased diastolic BP, lack of PCI during hospitalization, increased creatinine level and increased HR (with different cut-offs according to EF categories) were found as predictors whatever the EF at 6 and 12 months. Optimal prognostic cut-offs of heart rate were identified for Heart Failure with reduced EF at 100 bpm, for Heart Failure with mid-range EF at 90 bpm and for Heart Failure with preserved EF at 80 bpm for both 6 and 12 months.
CONCLUSION
Our study suggests that HR at admission appears to be an independent prognostic parameter in AHF patients in sinus rhythm irrespective of EF and can be used to classify patients according to the severity of the disease.

Identifiants

pubmed: 32312619
pii: S0953-6205(20)30136-9
doi: 10.1016/j.ejim.2020.04.022
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-94

Informations de copyright

Copyright © 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of conflict of interest The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BT and FF are employees of Institut de Recherches Internationales Servier (IRIS). All authors declare no potential conflict of interest related to this article.

Auteurs

Jiri Jarkovsky (J)

Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Jindrich Spinar (J)

Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Benoit Tyl (B)

Department of Cardiovascular Translational and Clinical Research, Institut de Recherches Internationales Servier (IRIS), France; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Françoise Fougerousse (F)

Department of Cardiovascular Translational and Clinical Research, Institut de Recherches Internationales Servier (IRIS), France; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Jiri Vitovec (J)

Medical Faculty, Masaryk University, Brno, Czech Republic; First Department of Cardiovascular Internal Medicine, University Hospital St Anne's, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Ales Linhart (A)

2nd Department of Cardiovascular Internal Medicine, First Medical Faculty, Charles University, Prague and General Teaching Hospital of Prague, Prague, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Petr Widimsky (P)

University Hospital Kralovske Vinohrady and the Third Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Roman Miklik (R)

Cardiology Department, University Hospital Plzen, Plzen, Czech Republic; Cardiology Department, Hospital Podlesi, Trinec, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Lenka Spinarova (L)

Medical Faculty, Masaryk University, Brno, Czech Republic; First Department of Cardiovascular Internal Medicine, University Hospital St Anne's, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Jan Belohlavek (J)

2nd Department of Cardiovascular Internal Medicine, First Medical Faculty, Charles University, Prague and General Teaching Hospital of Prague, Prague, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Filip Malek (F)

Department of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Marian Felsoci (M)

Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Jiri Kettner (J)

Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic; Department of Internal Medicine, University Hospital Olomouc, Olomouc, Czech Republic.

Petr Ostadal (P)

Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic; Department of Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Jan Vaclavik (J)

Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic; Université Paris Diderot, PRES Sorbonne Paris Cité, France.

Ladislav Dusek (L)

Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Petr Lokaj (P)

Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic.

Alexandre Mebazaa (A)

Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic; Department of Anaesthesiology and Critical Care and Burn unit, APHP, Saint Louis Lariboisière University Hospitals, Paris, France; U 942 INSERM, Paris, France; Cardiology Department, Lariboisière University Hospitals, Paris, France.

Alain Cohen Solal (A)

Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic; Department of Anaesthesiology and Critical Care and Burn unit, APHP, Saint Louis Lariboisière University Hospitals, Paris, France; Cardiology Department, Lariboisière University Hospitals, Paris, France.

Jiri Parenica (J)

Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic; Department of Cardiology, Na Homolce Hospital, Prague, Czech Republic. Electronic address: jiri.parenica@atlas.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH